Acadian Asset Management LLC Equillium, Inc. Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 39,475 shares of EQ stock, worth $36,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,475
Previous 108,691
63.68%
Holding current value
$36,711
Previous $40,000
70.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EQ
# of Institutions
30Shares Held
11.5MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$4.14 Million0.35% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$4.14 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$766,4040.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$522,918100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny274KShares$254,9130.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $31.9M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...